Lite Strategy (LITS) Other Non Operating Income (2011 - 2025)
Lite Strategy (LITS) posted quarterly Other Non Operating Income of $541000.0 for Q4 2025, up 54200.0% quarter-over-quarter from -$1000.0 in Q1 2025.
Lite Strategy (LITS) Other Non Operating Income (2011 - 2025) Analysis & Trends
Lite Strategy's Other Non Operating Income history runs 10 years deep, the most recent figure standing at $541000.0 for Q4 2025.
- In Q4 2025, Other Non Operating Income changed N/A year-over-year to $541000.0; the TTM figure through Mar 2026 stood at $541000.0 (up 1302.22% YoY), while the FY2025 annual figure was -$16000.0, up 60.98% from the prior year.
- Other Non Operating Income for Q4 2025 stood at $541000.0, up from -$1000.0 in the prior quarter.
- The five-year high for Other Non Operating Income was $17.6 million in Q2 2021, with the low at -$34000.0 in Q2 2024.
- The 5-year median for Other Non Operating Income is -$2000.0 (2022), against an average of $1.6 million.
- The sharpest annual moves came in 2021 and 2024: Other Non Operating Income surged 587900.0% in 2021, then slumped 900.0% in 2024.
- Lite Strategy's Other Non Operating Income stood at $2.6 million in 2021, then plunged by 100.15% to -$4000.0 in 2022, then jumped by 50.0% to -$2000.0 in 2023, then plunged by 400.0% to -$10000.0 in 2024, then surged by 5510.0% to $541000.0 in 2025.
- Business Quant data shows LITS's Other Non Operating Income at $541000.0 in Q4 2025, -$1000.0 in Q1 2025, and -$10000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Lite Strategy | 35.71 Mn | 28.17 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 541,000.00 |
| Mar 31, 2025 | -1,000.00 |
| Sep 30, 2024 | -10,000.00 |
| Jun 30, 2024 | -34,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | -2,000.00 |
| Sep 30, 2023 | -1,000.00 |
| Dec 31, 2022 | -4,000.00 |
| Sep 30, 2022 | -2,000.00 |
| Jun 30, 2022 | -6,000.00 |
| Sep 30, 2021 | 2.59 Mn |
| Jun 30, 2021 | 17.64 Mn |
| Mar 31, 2021 | -13,000.00 |
| Dec 31, 2020 | 7.08 Mn |
| Sep 30, 2020 | 13.22 Mn |
| Jun 30, 2020 | 3,000.00 |
| Dec 31, 2019 | -8.44 Mn |
| Sep 30, 2019 | 9.27 Mn |
| Jun 30, 2019 | 27.63 Mn |
| Mar 31, 2019 | -5.20 Mn |